Skip to main content
. 2013 Apr 3;8(4):e58892. doi: 10.1371/journal.pone.0058892

Figure 7. Effect of 12 weeks treatment with inhaled Budesonide and Formoterol.

Figure 7

Pediatric patients with MA/PR were treated with Budesonide and Formoterol for 12 weeks and the effect was evaluated before and after the treatment on A) plasma IL-17A levels (pg/ml); B) CD4+ IL-17A+T-cells (%); C) Ss IL-17A levels (pg/g sputum). Results are expressed as individual data points and the lateral bars represent median (25–75 percentiles). Statistical analysis was performed by Wilcoxon U-test. Significance was at p<0.05.